Tirzepatide is a synthetic peptide and dual agonist of the GIP and GLP-1 receptors, two incretin signalling pathways. Simultaneous activation of GIP and GLP-1 allows researchers to study insulin secretion, food-intake regulation, gastric emptying and overall energy balance within one model.

Research focus:
• glucose metabolism
• body-weight regulation
• insulin signalling
• broader metabolic
• cardiovascular outcomes

Variant: 30 mg

For laboratory and research purposes only. Not intended for use in humans or animals.

Bacteriostatic water (BAC water) is selected for reconstitution of this product. Follow the specification of the particular material and the selected diluent volume during preparation. The calculator is intended only for mathematical concentration conversion.

For laboratory and research use only. Not intended for use in humans or animals.

1. Dry powder / lyophilised material (-20 °C):
For long-term storage, keep the original unopened vial at approximately -20 °C, protected from light and moisture. For many lyophilised peptides and proteins, properly stored material may remain stable for approximately 12 to 24 months, and sometimes longer. The exact period depends on the specific compound, purity and batch documentation.

2. After reconstitution (2–8 °C):
If the compound is compatible with the selected diluent, store the reconstituted solution generally at 2–8 °C, protect it from light and do not freeze. For many peptide solutions, approximately 3 to 4 weeks is used as a practical in-use period, but this is not a universal stability guarantee. Microbiological safety depends on the diluent used and aseptic handling.

Always follow the specific storage requirements for the compound and the documentation for the particular batch.